SCHEMBL7327170

SCHEMBL7327170

Cc1cc(C(C)(C)C)oc1C=O

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TP53 P04637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
ALOX15 P16050 1/20 0.33
MAPK1 P28482 1/20 0.32
POLB P06746 1/20 0.31
PKM P14618 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6626531 0.75
SCHEMBL3102495 0.71 L3MBTL1 (0.47) MEN1KMT2AALDH1A1TSHRNPSR1
SCHEMBL10811609 0.70
SCHEMBL6355058 0.70
SCHEMBL6756326 0.70
SCHEMBL528110 0.70
SCHEMBL27953557 0.70
SCHEMBL1603169 0.67 ALDH1A1 (0.33) ALDH1A1TSHRL3MBTL1
SCHEMBL31331625 0.65 ALDH1A1 (0.42) ALDH1A1TSHRL3MBTL1POLB
SCHEMBL28026992 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5545645-A Heterocyclic derivatives in the treatment of ischaemia and related diseases SYNTEX PHARMACEUTICALS, LIMITED (GB) 1996-08-13 US disclosed
EP-0693062-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LTD. (GB) 1996-01-24 EP disclosed
US-5428037-A Piperazine derivatives; calcium and sodium channel antagonists SYNTEX PHARMACEUTICALS, LTD. (GB) 1995-06-27 US disclosed
WO-1994024116-A1 HETEROCYCLIC DERIVATIVES IN THE TREATMENT OF ISCHAEMIA AND RELATED DISEASES SYNTEX PHARMACEUTICALS LIMITED (GB) 1994-10-27 WO disclosed